Selecting an E-cigarette for Use in Smoking Cessation Interventions and Healthcare Services: Findings from Patient and Public Consultation for the COSTED Trial

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Mar 5

PMID 38443079

Authors

Pippa Belderson

Emma Ward

Ian Pope

Caitlin Notley

Affiliations

Soon will be listed here.

Abstract

Objectives: The Cessation of Smoking Trial in the Emergency Department (COSTED) trial aims to ascertain whether brief advice, the provision of an e-cigarette starter kit and referral to stop smoking services (SSS), increases smoking cessation in people attending the emergency department. Patient and public involvement (PPI) and scoping work were undertaken to select an appropriate e-cigarette for the trial.

Design And Setting: PPI consultation and feasibility scoping about potential devices with a professional and lay panel, all based in England. Consultation was via email, telephone or video interview. This work took place between April and July 2021, prior to recruitment commencing for the COSTED trial.

Participants: A professional panel (n=7) including representatives from academia, SSS and the independent vaping industry, and a PPI lay panel (n=3) who smoke or vape.

Results: The professional panel recommended a shortlist of devices which were tested by the PPI lay panel. Key criteria for selecting an appropriate e-cigarette for smoking cessation intervention include satisfaction, usability, affordability and availability. Simplicity of use was highlighted by the PPI lay panel, who found refillable devices complex, and availability of consumables was highlighted as more important than price by both panels. The pod device selected for inclusion was rated highly for satisfaction and usability and had mid-price range and consumables which were widely available.

Conclusions: To select the most appropriate device for the COSTED trial, each criterion required assessment to ensure the best fit to the intervention context and needs of the target population. There is a need for guidance to help enable decision-making about choice of vape products, tailored to service users' needs. We propose a bespoke checklist template, based on our findings, to assist with this process. This has applicability to the recent government announcement of a 'Swap to Stop' programme, offering a vaping starter kit to smokers across England, allowing services flexibility to shape their own programmes and models of delivery.

Trial Registration Number: Clinical trial number NCT04854616; pre-results.

Citing Articles

Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Wu A Cochrane Database Syst Rev. 2025; 1:CD010216.

PMID: 39878158 PMC: 11776059. DOI: 10.1002/14651858.CD010216.pub9.

Providing an e-cigarette starter kit for smoking cessation and reduction as adjunct to usual care to smokers with a mental health condition: findings from the ESCAPE feasibility study.

Kale D, Beard E, Marshall A, Pervin J, Wu Q, Ratschen E BMC Psychiatry. 2025; 25(1):13.

PMID: 39754165 PMC: 11699696. DOI: 10.1186/s12888-024-06387-7.

Electronic Cigarettes and Tobacco Product Cessation: A Survey of Healthcare Providers' Opinions on Safety and Recommendation.

Chinwong S, Penthinapong T, Tengcharoenphongthorn P, Pingkaew S, Siriwattana K, Phrommintikul A Healthcare (Basel). 2024; 12(14).

PMID: 39057553 PMC: 11275567. DOI: 10.3390/healthcare12141410.

References

Baker A, Wilson S, Hayes J . Flavor and product messaging are the two most important drivers of electronic cigarette selection in a choice-based task. Sci Rep. 2021; 11(1):4689. PMC: 7907091. DOI: 10.1038/s41598-021-84332-4. View

Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M . Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008; 337:a1655. PMC: 2769032. DOI: 10.1136/bmj.a1655. View

Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith K, Bisal N . E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT. Health Technol Assess. 2019; 23(43):1-82. PMC: 6732716. DOI: 10.3310/hta23430. View

Dawkins L, Kimber C, Doig M, Feyerabend C, Corcoran O . Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Psychopharmacology (Berl). 2016; 233(15-16):2933-41. DOI: 10.1007/s00213-016-4338-2. View

Notley C, Ward E, Dawkins L, Holland R . The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention. Harm Reduct J. 2018; 15(1):31. PMC: 6011187. DOI: 10.1186/s12954-018-0237-7. View

Coffey M, Cooper-Ryan A, Houston L, Thompson K, Cook P . Using e-cigarettes for smoking cessation: evaluation of a pilot project in the North West of England. Perspect Public Health. 2020; 140(6):351-361. PMC: 7683886. DOI: 10.1177/1757913920912436. View

Notley C, Gentry S, Cox S, Dockrell M, Havill M, Attwood A . Youth use of e-liquid flavours-a systematic review exploring patterns of use of e-liquid flavours and associations with continued vaping, tobacco smoking uptake or cessation. Addiction. 2021; 117(5):1258-1272. PMC: 9299186. DOI: 10.1111/add.15723. View

Cox S, Notley C . Cleaning up the science: the need for an ontology of consensus scientific terms in e-cigarette research. Addiction. 2021; 116(5):997-998. DOI: 10.1111/add.15374. View

Leavens E, Nollen N, Ahluwalia J, Mayo M, Rice M, Brett E . Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod-based e-cigarettes. Addiction. 2021; 117(1):207-215. PMC: 8655025. DOI: 10.1111/add.15597. View

10.

Notley C, Belderson P, Ward E, Wade J, Clarke H . A Pilot E-Cigarette Voucher Scheme in a Rural County of the United Kingdom. Nicotine Tob Res. 2022; 25(3):586-589. DOI: 10.1093/ntr/ntac178. View

11.

Ward E, Cox S, Dawkins L, Jakes S, Holland R, Notley C . A Qualitative Exploration of the Role of Vape Shop Environments in Supporting Smoking Abstinence. Int J Environ Res Public Health. 2018; 15(2). PMC: 5858366. DOI: 10.3390/ijerph15020297. View

12.

Farrimond H, Abraham C . Developing E-cigarette friendly smoking cessation services in England: staff perspectives. Harm Reduct J. 2018; 15(1):38. PMC: 6076389. DOI: 10.1186/s12954-018-0244-8. View

13.

Zare S, Nemati M, Zheng Y . A systematic review of consumer preference for e-cigarette attributes: Flavor, nicotine strength, and type. PLoS One. 2018; 13(3):e0194145. PMC: 5854347. DOI: 10.1371/journal.pone.0194145. View

14.

Tattan-Birch H, Brown J, Jackson S . 'Give 'em the vape, sell 'em the pods': razor-and-blades methods of pod e-cigarette pricing. Tob Control. 2021; 31(6):773-774. PMC: 9606490. DOI: 10.1136/tobaccocontrol-2020-056354. View

15.

Du P, Bascom R, Fan T, Sinharoy A, Yingst J, Mondal P . Changes in Flavor Preference in a Cohort of Long-Term Electronic Cigarette Users. Ann Am Thorac Soc. 2020; 17(5):573-581. PMC: 7193816. DOI: 10.1513/AnnalsATS.201906-472OC. View

16.

Hartmann-Boyce J, McRobbie H, Lindson N, Bullen C, Begh R, Theodoulou A . Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021; 4:CD010216. PMC: 8092424. DOI: 10.1002/14651858.CD010216.pub5. View

17.

Zare S, Zheng Y . Consumer Preferences for E-cigarette Flavor, Nicotine Strength, and Type: Evidence from Nielsen Scanner Data. Nicotine Tob Res. 2020; 23(5):823-828. DOI: 10.1093/ntr/ntaa238. View

18.

Czoli C, Goniewicz M, Islam T, Kotnowski K, Hammond D . Consumer preferences for electronic cigarettes: results from a discrete choice experiment. Tob Control. 2015; 25(e1):e30-6. DOI: 10.1136/tobaccocontrol-2015-052422. View

19.

Notley C, Clark L, Belderson P, Ward E, Clark A, Parrott S . Cessation of smoking trial in the emergency department (CoSTED): protocol for a multicentre randomised controlled trial. BMJ Open. 2023; 13(1):e064585. PMC: 9853266. DOI: 10.1136/bmjopen-2022-064585. View